Compare Mesoblast Limited (MESO) vs Yum! Brands, Inc. (YUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Yum! Brands, Inc. — how do they compare? Mesoblast Limited trades at $14.23 (market cap $1.75B), while Yum! Brands, Inc. trades at $144.65 (market cap $39.02B). The key difference: Yum! Brands, Inc. is far larger — about 22.3× Mesoblast Limited's market cap, and Yum! Brands, Inc. pays a 2.1% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mesoblast Limited for 14 Days and Yum! Brands, Inc. for 132 Days on average.
| MESO | YUM | |
|---|---|---|
Market Cap | $1.75B | $39.02B |
Volume | 239,027 | 2,597,636 |
Sector | Health | Consumer Cyclical |
52-Week High | $20.96 | $168.16 |
52-Week Low | $13.19 | $135.77 |
Typical Hold Time | 14 Days | 132 Days |
Enterprise Value | $1.83B | $50.63B |
Dividend Yield | — | 2.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $13.94, up 2.42% with bearish technical signals from moving averages. The company reported substantial revenue growth to $120 million in 2026 but remains unprofitable with a -47.82% net margin. Recent FDA approval for Ryoncil potency assay and completion of Phase 3 back pain trial represent significant operational milestones. Cash position remains strong at $161.16 million, though debt levels require monitoring.
While MESO shows promising revenue growth and pipeline progress, persistent losses and negative ROE present fundamental challenges. Analyst consensus leans bullish with 45% buy ratings, but technical indicators suggest near-term caution. The stock offers speculative growth potential contingent on successful commercialization and path to profitability.
YUM trades at $140.35, up 0.36% today, with a bullish technical signal despite mixed moving averages. Revenue grew to $8.21B in 2025, with net income of $1.56B and strong cash flow. Recent news highlights KFC's Open House launch and the completed Pizza Hut sale, streamlining the portfolio. Analysts maintain a consensus Buy rating with a $170.44 target, though some express caution amid sector pressures.
The outlook is positive with earnings beats and strategic refocusing, but risks include high debt levels and consumer spending sensitivity. Upside potential exists if growth initiatives succeed, yet investors should weigh competitive and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Yum! Brands, Inc.
Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →
